Home › Janssen, Bayer HealthCare announce results from landmark studies...
 

Keywords :   


Janssen, Bayer HealthCare announce results from landmark studies...

2015-09-02 08:58:45| Chemicals - Topix.net

Janssen Pharmaceuticals, Inc., and its development partner, Bayer HealthCare, today announced results from PMSS and XANTUS , their landmark real-world studies evaluating the safety of XARELTO in people with non-valvular atrial fibrillation . The results found the rates and patterns of major bleeding in routine clinical practice were low and generally consistent with those observed in Phase 3 clinical research.

Tags: results studies healthcare announce

Category:Chemicals

Latest from this category

All news
28.09Weekly Recap: AkzoNobel, BASF, Axalta, PPG Top This Weeks Stories
27.09Positive Development for Jotun After First Eight Months of 2028
27.09Graco Signs Definitive Agreement to Acquire Corob
27.09BASF Presents New Corporate Strategy
26.09Advanced Polymer Coatings Signs Deal to Coat for New Build Tankers Union Maritime
26.09Jeff McManus Appointed Senior VP of Americas at allnex
26.09AkzoNobel Develops Particle Technology for Metal Effect Powder Coatings
26.09Behr Paint Company Introduces Women in Paint in Canada
Chemicals »
28.09Hurricane Isaac Graphics
28.09Hurricane Isaac Forecast Discussion Number 12
28.09Tropical Storm Joyce Graphics
28.09Hurricane Isaac Wind Speed Probabilities Number 12
28.09Hurricane Isaac Forecast Advisory Number 12
28.09Hurricane Isaac Public Advisory Number 12
28.09Summary for Hurricane Isaac (AT5/AL102024)
28.09Tropical Storm Joyce Wind Speed Probabilities Number 6
More »